However, it remains a challenge to locally increase TREM2 expression according to the clinical symptoms and laboratory tests of AD patients while avoiding the toxic effects of activating TREM2-expressing macrophages in other tissues, e.g., tumor growth and immune evasion. This evidence concerns the gene TREM2 and Alzheimer disease.